NCT00138554
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
7,997 public trials
712 recruiting studies
Diabetes Mellitus, Type 2 trial results
Completed
Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 Diabetes
NCT01562561
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Shatin, New Territories, Hong Kong
- Novo Nordisk Investigational Site Kota Bharu, Kelantan, Malaysia
- Novo Nordisk Investigational Site Marikina City, Philippines
- Novo Nordisk Investigational Site Pasig, Philippines
Completed
Comparison of Repaglinide and Metformin Administered Alone or in Combination in Type 2 Diabetes
NCT01720290
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
- Novo Nordisk Investigational Site Beijing, China
- Novo Nordisk Investigational Site Shanghai, China
NCT00568074
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Shanghai, Shanghai Municipality, China
- Novo Nordisk Investigational Site Shanghai, Shanghai Municipality, China
- Novo Nordisk Investigational Site Chengdu, Sichuan, China
- Novo Nordisk Investigational Site Beijing, China
NCT01720303
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
- Novo Nordisk Investigational Site Shanghai, Shanghai Municipality, China
- Novo Nordisk Investigational Site Shanghai, Shanghai Municipality, China
NCT01698931
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Padova, Italy
Completed
Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 Diabetes
NCT01465152
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Barcelona, Spain
- Novo Nordisk Investigational Site Benamargosa, Spain
- Novo Nordisk Investigational Site Burlata, Spain
- Novo Nordisk Investigational Site Camas, Spain
NCT00568984
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
- Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
- Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
- Novo Nordisk Investigational Site Tianjin, Tianjin Municipality, China
NCT01605773
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Houston, Texas, United States
NCT01498913
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Seoul, South Korea